Tuesday - March 31, 2026

Hemophilia B Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Pfizer, Spark Therapeutics, Sanofi, Alnylam Pharma, CSL Behring, uniQure, Novo Nordisk

The Key Hemophilia B Companies in the market include – Belief Biomed, ISU ABXIS, TiumBio, Be Biopharma, Regeneron Pharmaceuticals, Pfizer, Biocad, CSL Behring, Shanghai Vitalgen BioPharma, Baxalta, Amarna therapeutics, Catalyst Biosciences, Freeline Therapeutics, Belief BioMed, Centessa Pharmaceuticals, Novo Nordisk, Sanofi, … Continue reading

Hidradenitis Suppurativa Market: High-Growth Opportunities for Investors to 2036 – DelveInsight | AbbVie, Novartis, UCB Biopharma, Eli Lilly, Institut Pasteur, UCB Biopharma SRL, MoonLake Immunothera

The Key Hidradenitis Suppurativa Companies in the market include – Kymera Therapeutics, CSL Behring, Azora Therapeutics, Union Therapeutics, Eli Lilly and company, Boehringer Ingelheim, ACELYRIN, Incyte Corporation, InflaRx, Novartis, ChemoCentryx, Janssen Pharmaceutical/XBiotech, Aclaris Therapeutics, and others. DelveInsight’s “Hidradenitis Suppurativa Market … Continue reading

DigiMarCon Northern California 2026 Returns to San Francisco, Bringing the Future of Digital Marketing to the Global Stage

San Francisco, CA – DigiMarCon Northern California, the premier digital marketing, media, advertising, and business conference and exhibition in the CA, will return June 16-17, 2026, at the Grand Hyatt San Francisco Hotel in San Francisco, CA. The three-day event … Continue reading

TECHSPO Boston 2026 Unites Business, Tech and Marketing Leaders for High-Impact Expo

Boston, MA – TECHSPO Boston Technology Expo returns May 12-13, 2026, to the Hyatt Regency Boston Hotel, uniting business leaders, technologists, marketers, and innovators for a high-impact, two-day showcase of next-generation digital technology. Part of the globally recognized TECHSPO Event … Continue reading